Dolby Laboratories, Inc. (NYSE:DLB) major shareholder Dagmar Dolby sold 26,358 shares of the business’s stock in a transaction on Friday, July 5th. The shares were sold at an average price of $65.01, for a total transaction of $1,713,533.58. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Large shareholders that own 10% or more of a company’s shares are required to disclose their transactions with the SEC.

Dagmar Dolby also recently made the following trade(s):

  • On Wednesday, July 3rd, Dagmar Dolby sold 77,692 shares of Dolby Laboratories stock. The shares were sold at an average price of $65.17, for a total transaction of $5,063,187.64.
  • On Monday, July 1st, Dagmar Dolby sold 50,000 shares of Dolby Laboratories stock. The shares were sold at an average price of $65.06, for a total transaction of $3,253,000.00.
  • On Thursday, June 27th, Dagmar Dolby sold 51,777 shares of Dolby Laboratories stock. The shares were sold at an average price of $65.06, for a total transaction of $3,368,611.62.
  • On Tuesday, June 25th, Dagmar Dolby sold 15,617 shares of Dolby Laboratories stock. The shares were sold at an average price of $65.04, for a total transaction of $1,015,729.68.
  • On Friday, June 21st, Dagmar Dolby sold 93,113 shares of Dolby Laboratories stock. The shares were sold at an average price of $65.11, for a total transaction of $6,062,587.43.
  • On Wednesday, May 15th, Dagmar Dolby sold 50,000 shares of Dolby Laboratories stock. The shares were sold at an average price of $65.05, for a total transaction of $3,252,500.00.
  • On Wednesday, May 8th, Dagmar Dolby sold 46,781 shares of Dolby Laboratories stock. The shares were sold at an average price of $65.12, for a total transaction of $3,046,378.72.
  • On Friday, May 3rd, Dagmar Dolby sold 50,000 shares of Dolby Laboratories stock. The shares were sold at an average price of $65.73, for a total transaction of $3,286,500.00.
  • On Monday, May 6th, Dagmar Dolby sold 100,000 shares of Dolby Laboratories stock. The shares were sold at an average price of $65.49, for a total transaction of $6,549,000.00.
  • On Wednesday, May 1st, Dagmar Dolby sold 16,145 shares of Dolby Laboratories stock. The shares were sold at an average price of $65.08, for a total transaction of $1,050,716.60.

DLB opened at $63.96 on Friday. Dolby Laboratories, Inc. has a fifty-two week low of $58.17 and a fifty-two week high of $72.04. The firm has a fifty day moving average price of $63.47. The stock has a market capitalization of $6.61 billion, a PE ratio of 26.65, a price-to-earnings-growth ratio of 2.10 and a beta of 0.82.

Dolby Laboratories (NYSE:DLB) last released its quarterly earnings data on Wednesday, May 1st. The electronics maker reported $0.70 earnings per share for the quarter, beating analysts’ consensus estimates of $0.52 by $0.18. Dolby Laboratories had a net margin of 24.93% and a return on equity of 11.12%. The company had revenue of $338.26 million during the quarter, compared to analysts’ expectations of $337.45 million. During the same quarter in the previous year, the company earned $0.73 earnings per share. The firm’s revenue for the quarter was up 12.9% on a year-over-year basis. As a group, analysts predict that Dolby Laboratories, Inc. will post 2.38 EPS for the current year.

DLB has been the subject of a number of recent analyst reports. B. Riley set a $18.00 price objective on shares of TiVo and gave the company a “buy” rating in a report on Thursday, June 13th. Zacks Investment Research cut shares of Inflarx from a “buy” rating to a “hold” rating in a report on Friday, May 3rd. Finally, ValuEngine raised shares of Zynerba Pharmaceuticals from a “sell” rating to a “hold” rating in a report on Monday, April 1st. Two equities research analysts have rated the stock with a hold rating, three have given a buy rating and one has assigned a strong buy rating to the company’s stock. The company presently has an average rating of “Buy” and a consensus target price of $76.50.

Several hedge funds have recently added to or reduced their stakes in the company. Vanguard Group Inc increased its stake in shares of Dolby Laboratories by 4.0% during the third quarter. Vanguard Group Inc now owns 5,508,279 shares of the electronics maker’s stock worth $385,415,000 after purchasing an additional 209,633 shares in the last quarter. Timucuan Asset Management Inc. FL increased its stake in shares of Dolby Laboratories by 1.1% during the first quarter. Timucuan Asset Management Inc. FL now owns 1,268,686 shares of the electronics maker’s stock worth $79,889,000 after purchasing an additional 13,911 shares in the last quarter. Thrivent Financial for Lutherans increased its stake in shares of Dolby Laboratories by 17.1% during the fourth quarter. Thrivent Financial for Lutherans now owns 1,154,500 shares of the electronics maker’s stock worth $71,394,000 after purchasing an additional 168,214 shares in the last quarter. Blair William & Co. IL increased its stake in shares of Dolby Laboratories by 24.0% during the first quarter. Blair William & Co. IL now owns 849,045 shares of the electronics maker’s stock worth $53,464,000 after purchasing an additional 164,065 shares in the last quarter. Finally, OppenheimerFunds Inc. increased its stake in shares of Dolby Laboratories by 0.3% during the first quarter. OppenheimerFunds Inc. now owns 805,375 shares of the electronics maker’s stock worth $50,714,000 after purchasing an additional 2,657 shares in the last quarter. 55.98% of the stock is owned by institutional investors and hedge funds.

About Dolby Laboratories

Dolby Laboratories, Inc creates audio and imaging technologies that transform entertainment and communications at the cinema, at home, at work, and on mobile devices. The company develops and licenses its audio technologies, such as AAC & HE-AAC, a digital audio codec solution used for TVs, set-top boxes (STBs), personal computers (PCs), gaming consoles, mobile devices, and digital radio; AVC, a digital video codec with high bandwidth efficiency used in media devices; Dolby AC-4, an audio coding technology that delivers new audio experiences to a range of playback devices; and Dolby Atmos technology for home theaters, cinemas, device speakers, mobile devices, and headphones.

Featured Article: Do investors pay a separate front-end load every time they buy additional shares?

Insider Buying and Selling by Quarter for Dolby Laboratories (NYSE:DLB)

Receive News & Ratings for Dolby Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dolby Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.